DAREN TECHNOLOGY acquired by CIMG
Context
CIMG, through its subsidiary DZR, signed an agreement to acquire 100% of Daren Technology for approximately $40M in stock. The transaction features a highly structured Phased Payment consideration (6%, 14%, 28%, and 52%) released over 3.5 years. This earn-out structure is strictly tied to Daren achieving aggressive audited revenue targets, starting at $29M in 2026 and scaling to $257M by September 2029. This structure ensures alignment between the acquisition cost and the realized growth of the target's biopharmaceutical activities.
DAREN TECHNOLOGY, which reported an EBITDA margin of [members only] in 2026, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Daren Technology is a specialized firm in the biopharmaceutical sector, focused on technological innovation and model integration within the drug development value chain. It serves as a new growth engine for diversified Corporate groups looking to enter high-growth life sciences markets.
Ent. Value
$20–50M
Equity Value
[members only]
Multiples
EV / Revenue
1x–3x
EV / EBITDA
[members only]
EV / EBIT
[members only]
Historical Financials (USD)
Similar deals in Life Sciences
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 03/2026 | Abbott Laboratories | Exact Sciences | UNITED STATES | Diagnostic Equipment |
| 03/2026 | RESONETICS | RESOLUTION MEDICAL | UNITED STATES | Medical Devices |
| 02/2026 | IMA GROUP | PROSYS | IRELAND | Medical Devices |
| 02/2026 | NORD HOLDING | HALLMARQ VETERINARY IMAGING | UNITED KINGDOM | Diagnostic Equipment |
| 02/2026 | VIVO CAPITAL | DUTSCHER | FRANCE | Medical Consumables |
| 01/2026 | YOTTA CAPITAL | VILLARD | FRANCE | Medical Consumables |
| 01/2026 | FAGRON | UNIVERSITY COMPOUNDING PHARMACY (UCP) | UNITED STATES | Compounding |
| 01/2026 | ARDIAN | IVB Wellness Lab | SPAIN | Nutrition & Dietary Supplements |
| 12/2025 | MONTAGU PRIVATE EQUITY / Kohlberg | Teleflex Medical OEM | UNITED STATES | Medical Consumables |
| 12/2025 | CHARTERHOUSE | WINBACK | FRANCE | Medical Devices |
REFERENCES
Valuation range: EV $20–50M
Revenue range: $10–30M
EV/Revenue range: 1x - 3x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of DAREN TECHNOLOGY by CIMG are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.